REL-(3S,4R)-1-(4-FLUOROPHENYL)-3-((3R)-3-(2-FLUOROPHENYL)-3-HYDROXYPROPYL)-4-(4-HYDROXYPHENYL)-2-AZETIDINONE
UNII 8DEP9E76RF
Substance Identification & Data
This profile provides standardized clinical and technical data for Rel-(3s,4r)-1-(4-fluorophenyl)-3-((3r)-3-(2-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)-2-azetidinone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8DEP9E76RF.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1798008-25-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C24H21F2NO3 OBQFYRYCMDREFB-AKIFATBCSA-N;OBQFYRYCMDREFB-WWNPGLIZSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Rel-(3s,4r)-1-(4-fluorophenyl)-3-((3r)-3-(2-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)-2-azetidinone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.